The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment
Open accessAbstract
The presence of an intrahepatic cholangiocarcinoma (iCCA) in a cirrhotic liver is a contraindication for liver transplantation in most centers worldwide. Recent investigations have shown that “very early” iCCA (single tumors ≤2 cm) may have acceptable results after liver transplantation. This study further evaluates this finding in a larger international multicenter cohort. The study group was composed of those patients who were transplanted for hepatocellular carcinoma or decompensated cirrhosis and found to have an iCCA at explant pathology. Patients were divided into those with “very early” iCCA and those with “advanced” disease (single tumor >2 cm or multifocal disease). Between January 2000 and December 2013, 81 patients were found to have an iCCA at explant; 33 had separate nodules of iCCA and hepatocellular carcinoma, and 48 had only iCCA (study group). Within the study group, 15/48 (31%) constituted the “very early” iCCA group and 33/48 (69%) the “advanced” group. There were no significant differences between groups in preoperative characteristics. At explant, the median size of the largest tumor was larger in the “advanced” group (3.1 [2.5‐4.4] versus 1.6 [1.5‐1.8]). After a median follow‐up of 35 (13.5‐76.4) months, the 1‐year, 3‐year, and 5‐year cumulative risks of recurrence were, respectively, 7%, 18%, and 18% in the very early iCCA group versus 30%, 47%, and 61% in the advanced iCCA group, P = 0.01. The 1‐year, 3‐year, and 5‐year actuarial survival rates were, respectively, 93%, 84%, and 65% in the very early iCCA group versus 79%, 50%, and 45% in the advanced iCCA group, P = 0.02. Conclusion: Patients with cirrhosis and very early iCCA may become candidates for liver transplantation; a prospective multicenter clinical trial is needed to further confirm these results. (H epatology 2016;64:1178‐1188)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Self-citationMazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Self-citationRazumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
Clavien, P.-A., Lesurtel, M., Bossuyt, P. M., Gores, G. J., Langer, B., & Perrier, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70175-9 · Cited by 1,026
Self-citationYao, F. Y., Xiao, L., Bass, N. M., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01965.x · Cited by 562
Self-citationPalmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Meyer, C. G., Penn, I., & James, L. (2000) · Transplantation · doi:10.1097/00007890-200004270-00019 · Cited by 502
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study
Goodman, Z. D., Ishak, K. G., Langloss, J. M., Sesterhenn, I. A., & Rabin, L. (1985) · Cancer · doi:10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z · Cited by 440
Sapisochin, G., Goldaracena, N., Laurence, J. M., Dib, M., Barbas, A., Ghanekar, A., Cleary, S. P., Lilly, L., Cattral, M. S., Marquez, M., et al. (2016) · Hepatology · doi:10.1002/hep.28643 · Cited by 368
Self-citationVilana, R., Forner, A., Bianchi, L., García-Criado, Á., Rimola, J., de Lope, C. R., Reig, M., Ayuso, C., Brú, C., & Bruix, J. (2010) · Hepatology · doi:10.1002/hep.23600 · Cited by 318
Self-citationSpanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Sapisochin, G., Rodríguez de Lope, C., Gastaca, M., Ortiz de Urbina, J., Suarez, M. A., Santoyo, J., Castroagudín, J. F., Varo, E., López-Andujar, R., Palacios, F., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12591 · Cited by 197
Self-citationA Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria
Volk, M. L., Vijan, S., & Marrero, J. A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02138.x · Cited by 189
Sapisochin, G., de Lope, C. R., Gastaca, M., de Urbina, J. O., López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000494 · Cited by 185
Self-citationSakamoto, Y., Kokudo, N., Matsuyama, Y., Sakamoto, M., Izumi, N., Kadoya, M., Kaneko, S., Ku, Y., Kudo, M., Takayama, T., et al. (2016) · Cancer · doi:10.1002/cncr.29686 · Cited by 168
Spolverato, G., Kim, Y., Ejaz, A. M., Alexandrescu, S. T., Marques, H. P., Aldrighetti, L. A., Gamblin, T. C., Pulitanò, C., Bauer, T. W., Shen, F., et al. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.0219 · Cited by 121
Doussot, A., Koerkamp, B. G., Wiggers, J. K., Chou, J. F., Gönen, M., DeMatteo, R. P., Allen, P. J., Kingham, T. P., D'Angelica, M. I., & Jarnagin, W. R. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.04.009 · Cited by 99
Fisher, S. B., Patel, S. H., Kooby, D. A., Weber, S. M., Bloomston, M., Cho, C. S., Hatzaras, I. S., Schmidt, C. R., Winslow, E. R., Staley, C. A., et al. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00489.x · Cited by 84
Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants
Vallin, M., Stürm, N., Lamblin, G., Guillaud, O., Hilleret, M., Hervieu, V., Joubert, J., Abergel, A., Leroy, V., Boillot, O., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12108 · Cited by 41
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationCholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Brindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Moris, D., Palta, M., Kim, C., Allen, P. J., Morse, M. A., & Lidsky, M. E. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21759 · Cited by 451
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Self-citation
Metadata
- Authors
- Sapisochin, G., Facciuto, M., Rubbia‐Brandt, L., Marti, J., Mehta, N., Yao, F. Y., Vibert, E., Cherqui, D., Grant, D. R., Hernandez‐Alejandro, R., Dale, C. H., Cucchetti, A., Pinna, A., Hwang, S., Lee, S. G., Agopian, V. G., Busuttil, R. W., Rizvi, S., Heimbach, J. K., Montenovo, M., Reyes, J., Cesaretti, M., Soubrane, O., Reichman, T., Seal, J., Kim, P. T. W., Klintmalm, G., Sposito, C., Mazzaferro, V., Dutkowski, P., Clavien, P. A., Toso, C., Majno, P., Kneteman, N., Saunders, C., Bruix, J., & on behalf of the iCCA International Consortium
- Venue
- Hepatology
- Published
- 2016-08-24
- Volume
- 64
- Issue
- 4
- Pages
- 1178-1188
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2478338554
- Cited by
- 370
- References
- 21
- FWCI
- 25.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.